{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:20:46Z","timestamp":1788481246568,"version":"build-2803163510"},"reference-count":34,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>CONTEXT: Esophageal candidiasis is often observed in patients with risk factors for its development and fluconazole is the therapeutic choice for the treatment of this disease. OBJECTIVES: To determine its frequency, by performing upper digestive endoscopy; to determine Candida species involved in its pathogenesis and verify their distribution according with the predisposing factors and to determine susceptibility to fluconazole in the samples. METHODS: From March 2006 to April 2007, all patients submitted to esophagogastroduodenoscopy at the Digestive Endoscopy Unit in the Oswaldo Cruz University Hospital, Recife, PE, Brazil, were eligible for the study. Samples were collected from patients who presented lesions consistent with esophageal candidiasis in order to identify Candida species and verify their susceptibility to fluconazole. The predisposing factors for the occurrence of esophageal candidiasis were described. RESULTS: Of 2,672 patients referred to upper endoscopy at the Digestive Endoscopy Unit, 40 (1.5%) had endoscopic findings compatible with esophageal candidiasis. The average age was 49.1 years. Twenty one patients (52.5%) were less than 50 years old, of which 82.6% were infected with HIV. Most of them (52.5%) were males and 65.0% were inpatients. Diseases were identified in 90% of the patients and 21 (52.5%) were HIV positive. Concerning endoscopic findings, severe forms of esophagitis were found in 50% of the patients with CD4 count &lt;200. Non-albicans Candida species were isolated in 22.7% of HIV positive and in 45% HIV negative patients. A total of 6 (14.28%) samples were resistant to fluconazole, while 2 (4.76%) samples had dose depending susceptibility to this drug. CONCLUSIONS: Esophageal candidiasis prevalence was low, although within the results described by other authors. Male and inpatients were the most affected. The species isolated varied according to the characteristics of each group studied. Both, resistance and dose-depending susceptibility to fluconazole were considered high.<\/jats:p>","DOI":"10.1590\/s0004-28032009000100011","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T23:45:33Z","timestamp":1242863133000},"page":"32-37","source":"Crossref","is-referenced-by-count":7,"title":["The resistance to fluconazole in patients with esophageal candidiasis"],"prefix":"10.1590","volume":"46","author":[{"given":"Ana Botler","family":"Wilheim","sequence":"first","affiliation":[{"name":"University of Pernambuco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dem\u00f3crito de Barros","family":"Miranda-Filho","sequence":"additional","affiliation":[{"name":"University of Pernambuco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Albuquerque","family":"Nogueira","sequence":"additional","affiliation":[{"name":"University of Pernambuco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana Sette de Melo","family":"R\u00eago","sequence":"additional","affiliation":[{"name":"NKB Diagnosis of Pernambuco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedma de Magalh\u00e3es","family":"Lima","sequence":"additional","affiliation":[{"name":"Federal University of Pernambuco,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Maria Moreira Beltr\u00e3o","family":"Pereira","sequence":"additional","affiliation":[{"name":"University of Pernambuco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"375","article-title":"Esophageal candidiasis in patients without cellular immunity changes. Report of 7 cases","volume":"196","author":"Aleman C","year":"1996","journal-title":"Rev Clin Esp","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2565","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0016-5085(94)90613-0","article-title":"Esophageal infections: risk factors, presentation, diagnosis and treatment","volume":"106","author":"Baher PH","year":"1994","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref3","first-page":"133","article-title":"Treatment of fungal infections in hematology and oncology-guidelines of the infectious disease working party (AGIOF) of the German Society of Hematology and Oncology (DGOH)","volume":"82","author":"B\u00f6hme A","year":"2003","journal-title":"Ann Hematol","ISSN":"https:\/\/id.crossref.org\/issn\/0939-5555","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2006.11.017","article-title":"Risk of resistance associated with fluconazole prophylaxis: systematic review","volume":"54","author":"Brion LP","year":"2007","journal-title":"J Infect","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4453","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s100960050437","article-title":"Risk factors for esophageal candidiasis","volume":"19","author":"Chocarro Martinez A","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0722-2211","issn-type":"print"},{"key":"ref6","first-page":"1389","article-title":"Clinical and immunological study of 10 immunocompetent patients with esophageal candidiasis","volume":"132","author":"Cort\u00e9s C","year":"2004","journal-title":"Rev Med Chil","ISSN":"https:\/\/id.crossref.org\/issn\/0034-9887","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues","volume":"26","author":"Darouiche RO","year":"1998","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref8","series-title":"Therapy of digestive disorders. Philadelphia,","first-page":"767","volume-title":"Treatment of esophageal infections in the immunocompromised host","author":"Fraimow HS","year":"2000"},{"key":"ref9","first-page":"658","article-title":"Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycosis in immunocompromised patients","volume":"50","author":"Goa KL","year":"1995","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/497373","article-title":"A randomized study of the use of fluconazol in contiuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323\/Mycosis Study Group Study 40","volume":"41","author":"Goldman M","year":"2005","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1572-0241.2003.07626.x","article-title":"Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate","volume":"98","author":"Kanda N","year":"2003","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref12","first-page":"509","article-title":"Experience with Candida esophagitis in young patients without predisposing factors","volume":"41","author":"Kasapidis P","year":"1997","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1439-0507.2006.01237.x","article-title":"The first description of an oesophageal candidosis by Bernhardt Von Langenbeck in 1839","volume":"49","author":"Knoke M","year":"2006","journal-title":"Mycosis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1258\/0956462981920973","article-title":"Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients","volume":"9","author":"Laing RB","year":"1998","journal-title":"Int J STD AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0956-4624","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s100960050262","article-title":"Increased adherence of fluconazole-resistant isolates of candida species to explanted esophageal mucosa","volume":"18","author":"Lyman CA","year":"1999","journal-title":"Eur J Microbiol Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01324956","article-title":"Candida esophagitis","volume":"28","author":"Mathieson R","year":"1983","journal-title":"Dig Dis Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0163-2116","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00001574-198711000-00009","article-title":"Endoscopy","volume":"3","author":"McCloy RF","year":"1987","journal-title":"Curr Opin Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0267-1379","issn-type":"print"},{"key":"ref18","series-title":"Micologia m\u00e9dica \u00e0 luz de autores contempor\u00e2neos","first-page":"89","volume-title":"Leveduras: identifica\u00e7\u00e3o laboratorial","author":"Milan EP","year":"2004"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1572-0241.2005.41949.x","article-title":"Decline in esophageal candidiasis and use of antimycotics in European patients with HIV","volume":"100","author":"Mocroft A","year":"2005","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0889-8553(05)70294-6","article-title":"Oral and esophageal disorders","volume":"26","author":"Noyer CM","year":"1997","journal-title":"Gastroenterol Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0889-8553","issn-type":"print"},{"key":"ref21","first-page":"211","article-title":"Oesophageal candidiasis: clinical and mycological analysis","volume":"35","author":"Olmos MA","year":"2005","journal-title":"Acta Gastroenterol Latinoam","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9033","issn-type":"print"},{"key":"ref22","first-page":"503","article-title":"Esophageal candidiasis in HIV-negative patients","volume":"89","author":"Ortu\u00f1o CJA","year":"1997","journal-title":"Rev Esp Enferm Dig","ISSN":"https:\/\/id.crossref.org\/issn\/1130-0108","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas PG","year":"2004","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref24","first-page":"161","article-title":"Is endoscopic diagnosis of Candida albicans esophagitis reliable? Correlations with pathology and mycology","volume":"25","author":"Redah D","year":"2001","journal-title":"Gastroenterol Clin Biol","ISSN":"https:\/\/id.crossref.org\/issn\/0399-8320","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/clinids\/18.2.240","article-title":"Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis","volume":"18","author":"Redding S","year":"1994","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis","volume":"30","author":"Rex JH","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2169\/internalmedicine.46.1898","article-title":"An elderly case of type 2 diabetes which developed in association with oral and esophageal candidiasis","volume":"46","author":"Takasawa H","year":"2007","journal-title":"Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0918-2918","issn-type":"print"},{"key":"ref28","first-page":"515","article-title":"Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest","volume":"131","author":"Tapia C","year":"2003","journal-title":"Rev Med Chil","ISSN":"https:\/\/id.crossref.org\/issn\/0034-9887","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1442-2050.2003.00305.x","article-title":"Clinical findings and risk factors for candida esophagitis in outpatients","volume":"16","author":"Underwood JA","year":"2003","journal-title":"Dis Esophagus","ISSN":"https:\/\/id.crossref.org\/issn\/1120-8694","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2165\/00003495-200363100-00004","article-title":"Invasive oesophageal candidiasis: current and developing treatment options","volume":"63","author":"Vazquez JA","year":"2003","journal-title":"Drugs."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1442-2050.2006.00563.x","article-title":"A study of candida esophagitis in elderly patients attending a district general hospital in UK","volume":"19","author":"Weerasuriya N","year":"2006","journal-title":"Dis Esophagus","ISSN":"https:\/\/id.crossref.org\/issn\/1120-8694","issn-type":"print"},{"key":"ref32","series-title":"Meeting Abstracts of Digestive Disease Week, 2007","volume-title":"The relationship between immunological status and severity of endoscopic lesions in candida esophagitis is not perfect in HIV-Infected patients","author":"Werneck-Silva AL","year":"2007"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0016-5107(95)70139-7","article-title":"A technic to examine the underlying mucosa in patients with AIDS and severe candida esophagitis","volume":"42","author":"Wilcox CM","year":"1995","journal-title":"Gastrointest Endosc","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5107","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"9","author":"Wingard JR","year":"1991","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v46n1\/11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T03:46:00Z","timestamp":1495770360000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032009000100011&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0004-28032009000100011"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032009000100011","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}